| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/06/2004 | US20040087624 Analgesics; antiinflammatory agents; immunology; bone disorders; neurodegradation diseases |
| 05/06/2004 | US20040087623 Pyrazole derivatives against tgf overexpression |
| 05/06/2004 | US20040087621 N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists |
| 05/06/2004 | US20040087618 Halogen-substituted quinoline derivatives and ectoparasite control agent |
| 05/06/2004 | US20040087616 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease |
| 05/06/2004 | US20040087614 Method for treating damaged skin |
| 05/06/2004 | US20040087613 Prevention of adhesions with rapamycin |
| 05/06/2004 | US20040087612 Topical administering in aqueous solution |
| 05/06/2004 | US20040087611 Cancer treatment by combination therapy |
| 05/06/2004 | US20040087610 Method and composition for the treatment of cancer |
| 05/06/2004 | US20040087609 Process for producing camptothecin |
| 05/06/2004 | US20040087608 Glutamic acid antagonist |
| 05/06/2004 | US20040087607 Adjust intensity of analgesics; blocking gangliosides |
| 05/06/2004 | US20040087606 Shivering suppression during cooling to lower body temperature |
| 05/06/2004 | US20040087605 N-but-3-enyl norbuprenorphine and methods of use |
| 05/06/2004 | US20040087602 Topical viricide; photostabilizer for inorganic oxide pigment; 2-bromovinyl deoxyuridine mixtures |
| 05/06/2004 | US20040087600 Amino-substituted dihydropyrimido[4,5-D]pyrimidinone derivatives |
| 05/06/2004 | US20040087599 cGMP-PDE inhibitors for the treatment of erectile dysfunction |
| 05/06/2004 | US20040087598 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-1,3-dihydoimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 05/06/2004 | US20040087597 Preventives and remedies for complications of diabetes |
| 05/06/2004 | US20040087596 Using mixture of levodopa and glycine antagonist; side effect reduction |
| 05/06/2004 | US20040087595 1-aryl- or 1-alkylsulfony-heterocyclybenzazoles as 5-hydroxytryptamine-6 ligands |
| 05/06/2004 | US20040087594 Diaminothiazoles having antiproliferative activity |
| 05/06/2004 | US20040087592 Treatment of malaria with farnesyl protein transferase inhibitors |
| 05/06/2004 | US20040087591 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use |
| 05/06/2004 | US20040087590 Novel biphenyl and biphenyl-like cannabinoids |
| 05/06/2004 | US20040087588 Parp inhibitors |
| 05/06/2004 | US20040087585 Peptide deformylase inhibitors |
| 05/06/2004 | US20040087584 Antiinflammatory agents; cognition activators; asthma therapy; antiarthritic agents; side effect reduction |
| 05/06/2004 | US20040087582 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
| 05/06/2004 | US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists |
| 05/06/2004 | US20040087579 Antitumor agents, anticancer agents; synergistic mixture; side effect reduction |
| 05/06/2004 | US20040087578 Pharmaceutical compositions containing carvedilol and hydrochlorothiazide |
| 05/06/2004 | US20040087576 Cognition activators; psychological disorders; antidepressants; schizophrenia; therapy and administering drug |
| 05/06/2004 | US20040087575 Therapeutic chromone compounds |
| 05/06/2004 | US20040087572 Method for inhibiting cataracts |
| 05/06/2004 | US20040087571 Methods of using CCR1 antagonists as immunomodulatory agents |
| 05/06/2004 | US20040087569 N-heterocyclic bicyclic lactone compounds |
| 05/06/2004 | US20040087567 Anticancer agents; particularly liver cancer |
| 05/06/2004 | US20040087566 Enzyme inhibitors; anticancer agents |
| 05/06/2004 | US20040087565 Hormone replacement therapy |
| 05/06/2004 | US20040087564 Delivery composition and method |
| 05/06/2004 | US20040087563 Hormone replacement therapy with cardiovascular protection using antialdosteronic progestins |
| 05/06/2004 | US20040087561 Treatment of sexual dysfunction |
| 05/06/2004 | US20040087560 Leukemia; anticancer agents; antiproliferative agents |
| 05/06/2004 | US20040087559 Methods for prevention and treatment of cancer |
| 05/06/2004 | US20040087558 Analgesics; antiarthritic agents; osteoporosis |
| 05/06/2004 | US20040087557 Treating muscle wasting with selective androgen receptor modulators |
| 05/06/2004 | US20040087556 N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor |
| 05/06/2004 | US20040087555 Phosphohalohydrins, process for the production thereof and use thereof |
| 05/06/2004 | US20040087553 Diterpene compounds; prophylaxis of hypercholesterolemia and hypertriglyceridemia |
| 05/06/2004 | US20040087552 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/06/2004 | US20040087551 Intravenously administering a bisphosphonate |
| 05/06/2004 | US20040087550 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
| 05/06/2004 | US20040087549 Aryl phosphate derivatives of d4T having activity against resistant HIV strains |
| 05/06/2004 | US20040087548 Anticancer agents and treating immune disorders |
| 05/06/2004 | US20040087547 Orally administered antitumor agents |
| 05/06/2004 | US20040087546 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myeloproliferative diseases |
| 05/06/2004 | US20040087545 Method and composition for the treatment of a viral infection |
| 05/06/2004 | US20040087544 .1-10,000 mg/mL of a glycosaminoglycan, .001-5% of osmolarity-correcting agent, .0001-30% of a preservative of paraben, benzyl alchool, chlorbutanol, chlorcresol, benzetoin chloride, benzalconium chloride and solvents; ph 4.5-8.5 |
| 05/06/2004 | US20040087541 Crystalline and amorphous forms of beta-L-2'-deoxythymidine |
| 05/06/2004 | US20040087539 Method of treating conditions related to platelet activity |
| 05/06/2004 | US20040087538 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 05/06/2004 | US20040087534 2-100 nucleotides containing >/= 1 unmethylated cytosine-guanine dinucleotide; antisense therapies; in vivo hybridization probes; viricides |
| 05/06/2004 | US20040087531 Inhibiting expression of gene tpt1 |
| 05/06/2004 | US20040087528 Delivering plasmid vector encoding HERG (A561V) (human ether-a-go-go related gene) protein to cells afflicted with re-entrant atrial flutter mediated cardiac arrhythmia |
| 05/06/2004 | US20040087527 Methods for treatment of thiol-containing compound deficient conditions |
| 05/06/2004 | US20040087520 Compositions and methods for delivery of therapeutic agents |
| 05/06/2004 | US20040087519 Avermectin derivatives |
| 05/06/2004 | US20040087516 Releaving symptoms using antioxidant flavonoids; reduced side effects |
| 05/06/2004 | US20040087515 Compositions methods for improving cardio vascular function |
| 05/06/2004 | US20040087514 Triggering glucagon like peptide 1 secretion; nonglucose carbohydrate and soluble fiber; metabolic syndrome, diabetes, obesity, promotion of satiety |
| 05/06/2004 | US20040087513 Cardiac or cerebral ischemias; strokes |
| 05/06/2004 | US20040087510 Cardiovascular diseases and disorders; sustained delivery of nitric oxide |
| 05/06/2004 | US20040087508 Users for amino acid anticonvulsants |
| 05/06/2004 | US20040087497 CD10-activated prodrug compounds |
| 05/06/2004 | US20040087492 Involving production of lipid mediators, impairment of glycosaminoglycan functioning; sepsis |
| 05/06/2004 | US20040087490 Leucine with isoleucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine and/or histidine; tumor induced weight loss; kits |
| 05/06/2004 | US20040087489 Compositions and methods for the treatment of mycobacterial infections |
| 05/06/2004 | US20040087488 Hydrophilic biopolymer-drug conjugates, their preparation and use |
| 05/06/2004 | US20040087486 Inhibiting vascular occlusive events; reducing circulating count below normal levels without serious adverse consequence |
| 05/06/2004 | US20040087484 Treating sexual dysfunction associated with hypertension; angiotensin receptor blocker with either antihypertensive agent or HMG-CoA reductase inhibitor |
| 05/06/2004 | US20040087480 Modulating cellular differentiation and proliferation; wound repair, skin regeneration; human epithelial type 2 |
| 05/06/2004 | US20040087479 Composition and method for reducing the risk or progression of cardiovascular, glaucoma, tardive dyskinesia and other diseases |
| 05/06/2004 | US20040087035 Using myeloproliferative leukemic inhibitory agents to treatment and/ or prevention platelet related thrombotic and vaso-occlusive disorder |
| 05/06/2004 | US20040087018 Using vitamin d3, cytokine, antibody and dexamethasone mixture to identify and treat inflammatory or autoimmune diseases |
| 05/06/2004 | US20040086982 Using transgenic bacillus to ferment vitamin b5, valine and isoleucine |
| 05/06/2004 | US20040086907 Prevent Dna damage; antitumor, anticancer agents; blocking epidermal growth factor receptor |
| 05/06/2004 | US20040086902 Comprises nucleotide sequences coding fructosyltransferase for preparation of fructooligosaccharides and difructose dianhydrides for use as dietetic food or animal feed additive |
| 05/06/2004 | US20040086899 Compromises nuclelotide sequences coding polypeptides associated with elongation of fatty acid chains for treatment and prevention of skin, cardiovascular, inflammatory, gastrointestinal, respiratory system and bone disorders |
| 05/06/2004 | US20040086851 Anticancer agents |
| 05/06/2004 | US20040086585 Composition and methods for treating Alzheimer's disease and other amyloidoses |
| 05/06/2004 | US20040086582 Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms |
| 05/06/2004 | US20040086581 Bio-energetic joint and arthritis pain formula |
| 05/06/2004 | US20040086580 Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
| 05/06/2004 | US20040086579 Dietary supplement comprising parthenolide |
| 05/06/2004 | US20040086575 Anti-viral compositions and methods of making and using the anti-viral compositions |
| 05/06/2004 | US20040086574 Iron-free multi-vitamin/mineral/antioxidant formulation, designed to optimize health and wellness, minimize oxidative stress, and normalize homocysteine levels |
| 05/06/2004 | US20040086571 For therapy of dyslipidemia and dyslipoproteinemia |
| 05/06/2004 | US20040086570 Controlled-release dosage; therapy |